Literature DB >> 26667940

Do frailty and cognitive impairment affect dual-task cost during walking in the oldest old institutionalized patients?

Eduardo L Cadore1, Alvaro Casas-Herrero2, Fabricio Zambom-Ferraresi3, Alicia Martínez-Ramírez4, Nora Millor4, Marisol Gómez4, Ana B Bays Moneo3, Mikel Izquierdo5.   

Abstract

The objective of this study was to investigate dual-task costs in several elderly populations, including robust oldest old, frail oldest old with MCI, frail oldest old without MCI, and frail elderly with dementia. Sixty-four elderly men and women categorized into frail without MCI (age 93.4 ± 3.2 years, n = 20), frail with MCI (age 92.4 ± 4.2 years, n = 13), robust (age 88.2 ± 4.1 years, n = 10), and patients with dementia (age 88.1 ± 5.1 years, n = 21). Five-meter gait ability and timed-up-and-go (TUG) tests with single and dual-task performance were assessed in the groups. Dual-task cost in both 5-m habitual gait velocity test and TUG test was calculated by the time differences between single and dual-task performance. The robust group exhibited better 5-m gait and TUG test performances in the single and dual-task conditions compared with the other three groups (P < 0.001), and the frail and frail + MCI groups exhibited better performances than the dementia group (P < 0.001). No significant differences were observed between the frail and frail + MCI groups. However, all groups exhibited lower gait velocities in the verbal and arithmetic task conditions, but the dual-task cost of the groups were similar. Robust individuals exhibited superior single and dual-task walking performances than the other three groups, and the frail and frail + MCI individuals exhibited performances that were superior to those of the patients with dementia. However, the dual-task costs, i.e., the changes in gait performance when elderly participants switch from a single to a dual task, were similar among all four of the investigated groups. Therefore, these results demonstrated that the magnitude of the impairment in gait pattern is independent of frailty and cognitive impairment status.

Entities:  

Keywords:  Cognitive impairment; Dementia; Dual-task walking; Frailty; Oldest old

Mesh:

Year:  2015        PMID: 26667940      PMCID: PMC5005870          DOI: 10.1007/s11357-015-9862-1

Source DB:  PubMed          Journal:  Age (Dordr)        ISSN: 0161-9152


  38 in total

1.  Searching for an operational definition of frailty: a Delphi method based consensus statement: the frailty operative definition-consensus conference project.

Authors:  Leocadio Rodríguez-Mañas; Catherine Féart; Giovanni Mann; Jose Viña; Somnath Chatterji; Wojtek Chodzko-Zajko; Magali Gonzalez-Colaço Harmand; Howard Bergman; Laure Carcaillon; Caroline Nicholson; Angelo Scuteri; Alan Sinclair; Martha Pelaez; Tischa Van der Cammen; François Beland; Jerome Bickenbach; Paul Delamarche; Luigi Ferrucci; Linda P Fried; Luis Miguel Gutiérrez-Robledo; Kenneth Rockwood; Fernando Rodríguez Artalejo; Gaetano Serviddio; Enrique Vega
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-04-16       Impact factor: 6.053

2.  "Stops walking when talking" as a predictor of falls in elderly people.

Authors:  L Lundin-Olsson; L Nyberg; Y Gustafson
Journal:  Lancet       Date:  1997-03-01       Impact factor: 79.321

3.  Frailty in the clinical scenario.

Authors:  Leocadio Rodriguez-Mañas; Linda P Fried
Journal:  Lancet       Date:  2014-11-06       Impact factor: 79.321

Review 4.  Muscle power training in the institutionalized frail: a new approach to counteracting functional declines and very late-life disability.

Authors:  Mikel Izquierdo; Eduardo Lusa Cadore
Journal:  Curr Med Res Opin       Date:  2014-04-07       Impact factor: 2.580

Review 5.  Frailty and the older man.

Authors:  J Walston; L P Fried
Journal:  Med Clin North Am       Date:  1999-09       Impact factor: 5.456

6.  The Clinical Dementia Rating (CDR): current version and scoring rules.

Authors:  J C Morris
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

7.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

8.  Frailty and quality of life for people with Alzheimer's dementia and mild cognitive impairment.

Authors:  Aine M Ní Mhaoláin; Damien Gallagher; Lisa Crosby; Deirdre Ryan; Loretto Lacey; Robert F Coen; Davis Coakley; J Bernard Walsh; Conal Cunningham; Brian Lawlor
Journal:  Am J Alzheimers Dis Other Demen       Date:  2012-02       Impact factor: 2.035

9.  Deaths due to physical restraint.

Authors:  Andrea M Berzlanovich; Jutta Schöpfer; Wolfgang Keil
Journal:  Dtsch Arztebl Int       Date:  2012-01-20       Impact factor: 5.594

10.  Belt restraint reduction in nursing homes: design of a quasi-experimental study.

Authors:  Math J M Gulpers; Michel H C Bleijlevens; Erik van Rossum; Elizabeth Capezuti; Jan P H Hamers
Journal:  BMC Geriatr       Date:  2010-02-25       Impact factor: 3.921

View more
  3 in total

Review 1.  Frailty and Cognitive Function in Older Adults: A Systematic Review and Meta-Analysis of Cross-Sectional Studies.

Authors:  Talia L Robinson; Marissa A Gogniat; L Stephen Miller
Journal:  Neuropsychol Rev       Date:  2021-04-22       Impact factor: 7.444

2.  Relationship between a three-month physical conditioning "posture-balance-motricity and health education" (PBM-HE) program on postural and balance capacities of sedentary older adults: influence of initial motor profile.

Authors:  Pierre Louis Bernard; Hubert Blain; Aurelie Gerazime; Olivier Maurelli; Jean Bousquet; Grégory Ninot
Journal:  Eur Rev Aging Phys Act       Date:  2018-11-20       Impact factor: 3.878

3.  Dual-task performance in old adults: cognitive, functional, psychosocial and socio-demographic variables.

Authors:  María Campos-Magdaleno; Arturo Pereiro; Esperanza Navarro-Pardo; Onésimo Juncos-Rabadán; David Facal
Journal:  Aging Clin Exp Res       Date:  2021-10-14       Impact factor: 4.481

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.